title: Catheter ablation in supraventricular tachycardia.
abstract: The evolution of catheter ablation for the treatment of supraventricular tachycardias represents a major advance in the management of cardiac arrhythmias. Excellent results in the majority of patients undergoing the procedure, together with a low rate of early complications and a brief hospitalization, make catheter ablation a highly cost-effective permanent cure. At present, however, its place in relation to alternate therapies in the management of supraventricular tachycardias has not been clearly established owing to unresolved risk-benefit issues. Continuing technical advances will likely enable catheter ablation to be successfully applied to a broader range of cardiac arrhythmias.
authors.affiliation: Wisconsin Electrophysiology Group, Milwaukee Heart Institute of Sinai Samaritan Medical Center, USA.
authors.forename: S
authors.initials: S
authors.lastname: Deshpande
authors.forename: M
authors.initials: M
authors.lastname: Jazayeri
authors.forename: A
authors.initials: A
authors.lastname: Dhala
authors.forename: Z
authors.initials: Z
authors.lastname: Blanck
authors.forename: J
authors.initials: J
authors.lastname: Sra
authors.forename: S
authors.initials: S
authors.lastname: Bremner
authors.forename: M
authors.initials: M
authors.lastname: Akhtar
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D001283:Atrioventricular Node / Q000503:physiopathology / Q000601:surgery; D017115:Catheter Ablation / Q000191:economics / Q000295:instrumentation*; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D004562:Electrocardiography / Q000145:classification; D006801:Humans; D013617:Tachycardia, Supraventricular / Q000145:classification / Q000503:physiopathology / Q000601:surgery*
chemical_list: D000889:Anti-Arrhythmia Agents